DRSHF (DRSHF) Stock Price & Analysis

DRSHF (DRSHF) rose 3.17% to USD 1.3 as of September 8, 2026 at 20:09 UTC, according to Nexqual real-time market data.

DRSHF last closed at USD 1.26; the session ranged USD 1.3–1.36 on volume of 10,300 shares. Market capitalization is $1.20B, with a 52-week range of USD 1.01–4.39 (PNK). Source: Nexqual, September 8, 2026 at 20:09 UTC.

Key Statistics (as of September 8, 2026 at 20:09 UTC)

PriceUSD 1.3
Change▲ 3.17% (up)
Previous CloseUSD 1.26
OpenUSD 1.36
Day RangeUSD 1.3 – 1.36
52-Week RangeUSD 1.01 – 4.39
Volume10,300 shares
Market Cap$1.20B
ExchangePNK

Technical Analysis (DRSHF)

Nexqual's technical model rates DRSHF "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 20:09 UTC.

Overall SignalSTRONG SELL
RSI (14)45.45 (neutral)
vs SMA50Below (USD 1.45)
MACD-0.06 (negative)

Analyst Ratings (DRSHF)

Wall Street analysts rate DRSHF "None", per Nexqual as of September 8, 2026 at 20:09 UTC.

Consensus RatingNone

Earnings (DRSHF)

Source: Nexqual, September 8, 2026 at 20:09 UTC.

Financials & Fundamentals (DRSHF)

Total Revenue$270.02M
Revenue Growth (YoY)+73.30%
Gross Margin+59.30%
Operating Margin-26.13%
Profit Margin-11.42%
ROE-9.90%
Debt / Equity5.4
Current Ratio4.3
Total Cash$178.48M
Total Debt$16.65M
Free Cash Flow$-16.57M

Source: Nexqual, September 8, 2026 at 20:09 UTC.

Financial Health Score (DRSHF)

Nexqual rates DRSHF's overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 20:09 UTC.

GrowthStrong — Revenue +276% YoY (annual)
ProfitabilityMixed — Gross margin 59%, operating -26%
Balance SheetStrong — $178M cash vs $17M debt, net cash position
Cash FlowWeak — FCF negative: -$17M, burning cash
EfficiencyCritical — ROE -10%, ROA -6.1%

Ownership (DRSHF)

Insider Ownership+4.90%
Institutional Ownership+37.78%
Shares Outstanding925.22M
Float859.88M

Source: Nexqual, September 8, 2026 at 20:09 UTC.

Leadership (DRSHF)

DRSHF is led by Angus Bean, MD, CEO & Director, per Nexqual as of September 8, 2026 at 20:09 UTC.

MD, CEO & DirectorAngus Bean
CFO & Joint Company SecretaryCarla Balanco
Chief Operating OfficerMichael Powell
Chief Technology OfficerAngus Harris
Director of Investor Relations & StrategyJoshua Thomas Bolot B.Com.

Major Backers & Investors (DRSHF)

Notable institutional backers of DRSHF include Fidelity, GLOBAL X FUNDS-Global X Defense Tech ETF, -iShares Defense Industrials Active ETF, according to Nexqual as of September 8, 2026 at 20:09 UTC.

Active Investors

InvestorStake
Fidelity5.81%
GLOBAL X FUNDS-Global X Defense Tech ETF1.01%
-iShares Defense Industrials Active ETF0.72%

Index Funds (Passive)

FundStake
Vanguard Group2.23%
BlackRock0.73%

Source: Nexqual, September 8, 2026 at 20:09 UTC.

Peers & Related Stocks

SymbolNamePriceChange
DRO.AXDRONE FPO [DRO]AUD 1.75▲ 0%
DRH.FDroneShield Limited REUR 1.09▼ 0.73%
DUKRDUKE Robotics Corp.USD 5.21▼ 6.96%
TAKOFVOLATUS AEROSPACE INC.USD 0.38▲ 2.08%
SPAISafe Pro Group Inc.USD 4.83▼ 3.4%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 20:09 UTC. This page is informational and not investment advice.